Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

CEC levels may be a useful marker for predicting prostate cancer progression.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Gene variation affects prostate issues and hair loss.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Serum triglyceride levels are not linked to prostate cancer risk.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Physical activity, height, and smoking affect prostate cancer risk.